Siblings Books/Book Section [1/1] Periodical Articles [65/66] Collection Statistics Item counts issued in 3 years:7(25.93%) Items With Fulltext:16(59.26%) Download counts of the item Download times greater than 0:16(100.00%) Download times greater than 100:16(100.00%) Total Bitstream Download Counts:5497(20.86%) Last Update: 2024-12-01 11:46 Top Upload Loading... Top Download Loading... Recent Submissions An integrated microfluidic device f... Phase 1 studies of D07001-F4 and D0... Comparative genomic analysis and it... A phase II trial of nivolumab, gemc... Improved survival with neoadjuvant ... A prospective phase II study of biw... Phase 1 study of nanoliposomal irin... An integrated microfluidic platform... A phase 2 study of liposomal irinot... TCOG T5217 trial: A phase II random...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 1-25 of 27. (2 Page(s) Totally) 1 2 > >> View [10|25|50] records per page

Date	Title	Relation
2023-06	Phase 1 studies of D07001-F4 and D07001-softgel capsule: Oral metronomic gemcitabine in subjects with advanced solid tumors	Journal of Clinical Oncology. 2023 Jun;41(16, Suppl.):Meeting Abstract 3148.
2022-10	An integrated microfluidic device for automated detection of cancer cells from bile for cholangiocarcinoma prognosis	MicroTAS 2022 - 26th International Conference on Miniaturized Systems for Chemistry and Life Sciences. 2022 Oct:229-230.
2022-07	Improved survival with neoadjuvant chemotherapy in stage III pancreatic cancer: A single institutional experience	Annals of Oncology. 2022 Jul;33(Suppl. 6):S535.
2022-07	A phase II trial of nivolumab, gemcitabine and S-1 as the frst-line treatment in patients with biliary tract cancer	Annals of Oncology. 2022 Jul;33(Suppl. 6):S478.
2022-06	Comparative genomic analysis and its prognostic impact on survival between viral hepatitis-related and non-viral hepatitis intrahepatic cholangiocarcinoma	Journal of Clinical Oncology. 2022 Jun;40(16, Suppl.):Abstract number 4120.
2022-02-01	A prospective phase II study of biweekly S-1, leucovorin and gemcitabine in elderly patients with locally advanced or metastatic pancreatic adenocarcinoma	Journal of Clinical Oncology. 2022 Feb 01;40(4, Suppl.):550.
2022-02	Phase 1 study of nanoliposomal irinotecan in combination with trifluridine/tipiracil in refractory solid tumors	Journal of Clinical Oncology. 2022 Feb;40(4, Suppl.):660.
2021-09	A phase II trial of nivolumab and gemcitabine and S-1 as the first-line treatment in patients with advanced biliary tract cancer	Annals of Oncology. 2021 Sep;32(Suppl. 5):S377.
2021-05	TCOG T5217 trial: A phase II randomized study of SLOG versus modified FOLFIRINOX as the first-line treatment in locally advanced or metastatic pancreatic ductal adenocarcinoma	Journal of Clinical Oncology. 2021 May;39(15, Suppl.):4143.
2021-05	A phase 2 study of liposomal irinotecan with 5-fluorouracil and leucovorin in squamous cell carcinoma of head and neck or esophagus after prior platinum-based chemotherapy or chemoradiotherapy	Journal of Clinical Oncology. 2021 May;39(15, Suppl.):Abstract number 6025.
2020-11	An integrated microfluidic platform for cholangiocarcinoma diagnosis from clinical bile juice samples by utilizing multiple affinity reagents	2020 IEEE 15th International Conference on Nano/Micro Engineered and Molecular System (IEEE Nems 2020). 2020 Nov:261-264.
2020-10	Psychosocial illness impacts of Taiwanese cancer survivors	Quality of Life Research. 2020 Oct;29(Suppl. 1):S91.
2019-02	Mutational landscape by targeted next-generation sequencing in EBV-associated lymphoepithelioma-like cholangiocarcinoma	Journal of Clinical Oncology. 2019 Feb;37(4, Suppl.):Abstract number 269.
2018-11	TCOG T1308 study: The final results of a phase II trial of modified gemcitabine plus S-1 combination as the first-line treatment in patients with advanced biliary tract cancer	Annals of Oncology. 2018 Nov;29(Suppl. 9):50.
2018-10	Multicenter, phase II trial of biweekly S-1, leucovorin (LV), oxaliplatin and gemcitabine (SLOG) in metastatic pancreatic adenocarcinoma (mPDAC): Final report of TCOG T1211 study	Annals of Oncology. 2018 Oct;29(Suppl. 8):Meeting Abstract 736P.
2018-05	A phase Ib study of ADI-PEG 20 plus pembrolizumab in advanced solid cancers	Journal of Clinical Oncology. 2018 May;36(15, Suppl. S):Meeting Abstract 2556.
2017-06	A new scoring system for primary central nervous system lymphoma - a retrospective multi-center analysis in Taiwan	Haematologica. 2017 Jun;102(Suppl. 2):691-692.
2017-02	A phase II trial of modified gemcitabine plus S-1 combination as the first-line treatment in patients with advanced biliary tract cancer	Journal of Clinical Oncology. 2017 Feb;35(4, Suppl.):417.
2016-02	Results of Phase II trial of AUY922, a novel heat shock protein inhibitor in patients with metastatic gastrointestinal stromal tumor (GIST) and imatinib and sunitinib therapy	Journal of Clinical Oncology. 2016 Feb;34(4, Suppl.):Meeting Abstract 134.
2016-02	Phase I trial of biweekly S-1, leucovorin, oxaliplatin, and gemcitabine (the SLOG regimen) in metastatic pancreatic adenocarcinoma (mPDAC)	Journal of Clinical Oncology. 2016 Feb;34(4, Suppl.):Meeting Abstract 369.
2016-02	Phase I dose-escalation study of sorafenib plus S-1 in refractory solid tumors	Journal of Clinical Oncology. 2016 Feb;34(4, Suppl.):Meeting Abstract 745.
2014-01	Impact of ROS1, ALK, and/or MET expression level on the therapeutic efficacy of GEMOX with and without cetuximab in ABTC: A post hoc analysis of a randomized phase II trial	Journal of Clinical Oncology. 2014 Jan;32(3 Suppl):Abstract number 267.
2013-05	Impact of virologic factors on recurrence-free survival in HBV-related hepatocellular carcinoma after surgical resection: Post hoc analysis from a prospective study with long-term follow-up	Journal of Clinical Oncology. 2013 May;31(15 Suppl.):Abstract number e15032.
2012-09	Heat shock protein 90 inhibition downregulates c-Kit expression in gist cells through diminishing transcription and enhancing protein degradation via both autophagy and proteasome pathways	Annals of Oncology. 2012 Sep;23(Suppl. 9):538.
2012-03	Involvement of autophagy in endogenous and NVP-AUY922-induced C-kit degradation in both imatinib-sensitive and -resistant gastrointestinal stromal tumor cells	Annals of Oncology. 2012 Mar;23(Suppl. 1):28.

Showing items 1-25 of 27. (2 Page(s) Totally) 1 2 > >> View [10|25|50] records per page